Medical University of South Carolina, Charleston, USA.
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221101860. doi: 10.1177/23247096221101860.
Infections due to nontuberculous mycobacterium (NTM) are important in chronically immunosuppressed populations and are a particular threat to solid organ transplant recipients (SOT). However, they are not a common occurrence and have protean manifestations, making it important that clinicians maintain a high degree of suspicion in the correct patient population. complex (MAC) usually presents with pulmonary involvement in immunocompetent population and disseminated disease in SOT patients with fever of unknown origin, lymphadenopathy, and cutaneous lesions being part of the well-known presentation. It is not commonly described as causing severe diarrhea. Here, we present an interesting case of a patient with a kidney and pancreas transplant who presented with debilitating wasting and chronic diarrhea. Biopsies and cultures confirmed MAC. To our knowledge, this is the first case report of MAC causing severe wasting diarrhea in renal transplant patients. The patient was treated with a multidrug regimen. Given the rare presentation of MAC presenting as chronic diarrhea, the treatment regimen is not standardized and infectious disease specialists should be involved early on. Up to 30% of renal transplant patients infected with NTM lose graft function and 20% die. Unfortunately, our patient suffered both these outcomes.
非结核分枝杆菌(NTM)感染在慢性免疫抑制人群中很重要,对实体器官移植受者(SOT)尤其构成威胁。然而,它们并不常见,且临床表现多样,因此临床医生在正确的患者群体中保持高度怀疑非常重要。 复合体(MAC)通常在免疫功能正常人群中表现为肺部受累,而在 SOT 患者中则表现为发热原因不明、淋巴结病和皮肤损伤,这些都是众所周知的表现的一部分。它通常不被描述为引起严重腹泻。在这里,我们介绍了一个有趣的病例,一名肾和胰腺移植患者出现严重消瘦和慢性腹泻。活检和培养证实了 MAC。据我们所知,这是首例 MAC 导致肾移植患者严重消瘦性腹泻的病例报告。患者接受了多药物治疗方案。鉴于 MAC 以慢性腹泻为表现的罕见情况,治疗方案尚未标准化,应尽早请传染病专家参与。多达 30%的感染 NTM 的肾移植患者会失去移植物功能,20%的患者会死亡。不幸的是,我们的患者都出现了这两种结果。